Biotech · Private company
Octant, Inc.
Track this companyFree. Adds Octant, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Phase 1b/2: Cohort 1 - OCT-980 TabletPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Phase 1b/2: Cohort 2 - OCT-980 TabletPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Phase 1b/2: Cohort 3 - OCT-980 TabletPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Phase 1b/2: Cohort 4 - OCT-980 TabletPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Phase 1b/2: Cohort 5 - OCT-980 TabletPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)PHASE1_PHASE2 · RECRUITING · started Mar 10, 2026ClinicalTrials.gov NCT07408232 · fetched Nov 12, 2026